Bei Akademie registrieren
Rovi, ES0157261019

Rovi stock pre-market at EUR 58.10: pharmaceutical laboratory

Published on 10/22/2026 at 08:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Rovi lists first nine months 2026 financial results for November 5, 2026. At Lang & Schwarz the stock trades pre-market at EUR 58.10 on October 22, 2026.

Business model and calendar

  • Rovi is a pharmaceutical laboratory.
  • First nine months 2026 financial results are scheduled for November 5, 2026.
  • Rovi stock trades pre-market at EUR 58.10 at 8:33 a.m. CEST at Lang & Schwarz on October 22, 2026.
Rovi, ES0157261019, Illustration mit AI erstellt.
Rovi, ES0157261019, Illustration mit AI erstellt.

Rovi is a pharmaceutical laboratory. Rovi stock trades pre-market at EUR 58.10 at 8:33 a.m. CEST at Lang & Schwarz on October 22, 2026.

Ahead of the Xetra open

The pre-market indication is being monitored ahead of the Xetra session. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Rovi stock.

Investor calendar and business

Rovi lists its first nine months 2026 financial results for November 5, 2026. The company operates as a pharmaceutical laboratory. Market context: Market report IBEX 35.

More news and analysis on Rovi stock

Disclaimer...
en | ES0157261019 | ROVI | boerse | 70390932 | bgmi